Latest abdominal pain Stories
SAN DIEGO, May 18, 2012 /PRNewswire/ -- Ocera Therapeutics Inc., a privately-held biopharmaceutical company focused on the development and commercialization of proprietary agents to treat gastrointestinal and liver diseases, announced today that it has received a CE Mark for Zysa(TM) (spherical carbon adsorbent, formerly AST-120) for the treatment of diarrhea predominant IBS (IBS-d), a condition affecting 10-15% of the Western world. Zysa is now ready for clinical use in the EU and...
Canada has one of the highest prevalence of IBD in the world with one in 160 Canadians living with IBD and 9,200 new cases diagnosed each year* MONTREAL, May 15, 2012 /CNW/ - As global attention turns towards inflammatory bowel disease (IBD) with the upcoming World IBD Day on May 19(th), a group of patients who live with this chronic condition are celebrating World IBD Day early with a public event taking place on May 15(th) at the ByWard Market in Ottawa. The group, called Gut...
Author and activist Karen Steward responded today to an article published in the February 2012 issue of "Nursing for Women's Health" stating that adhesions, or bands of internal scar tissue, caused by abdominal hysterectomy are a leading cause of small bowel obstruction among women who have had this operation. Steward, an advocate for patients with Adhesion Related Disorder (ARD), shared the author's concern that women who are having a hysterectomy are not being informed...
Author and adhesion activist Karen Steward today announced that Angela Patterson of Hillsborough, New Jersey had adhesion surgery in Germany with Dr. Daniel Kruschinski, the German surgeon whose innovative approach to adhesiolysis allowed Steward’s daughter to recover from fourteen years of adhesion pain. (PRWEB) May 07, 2012 After years of suffering from abdominal pain caused by scar tissue that formed following an appendectomy at the age of 19, Angela Patterson of Hillsborough, New...
According to court documents, on April 18th, 2012, the Accutane side effects lawsuit filed by Alton Herbert was transferred to the current Accutane Multi District Litigation (MDL 1626) in the Middle District of Florida. Herbert filed the lawsuit on January 12th, 2012, in the U.S. District Court for the Eastern District of Louisiana (case no. ATL-L-5981-11-MT) claiming that, after taking the generic Accutane “Claravis”, he was diagnosed with inflammatory bowel disease (Crohn's...
Irritable bowel syndrome (IBS) is hard to diagnose as well as treat, but researchers at the Sahlgrenska Academy, at the University of Gothenburg, Sweden, have discovered a way of confirming the disorder using stool samples. Irritable bowel syndrome (IBS) causes chronic or recurring problems with pain and discomfort in the abdomen together with changes in bowel habits. The syndrome is common and is believed to be linked to dysfunction of the stomach and intestines, but our understanding of...
Black youths less likely to get medication for abdominal pain than white patients Black children are less likely than white children to receive medication for abdominal pain in the emergency department (ED) even when they report severe pain, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston. "The emergency department serves as our nation's health care safety net, where all children can receive care regardless of...
Computed tomography (CT) utilization in pediatric patients with non-traumatic abdominal pain increased in emergency departments each year between 1999 and 2007, according to a new study published online in the journal Radiology. The study authors found no corresponding increase in ultrasound use during the same period, despite research supporting it as an important diagnostic tool for assessing pediatric abdominal pain. Non-traumatic abdominal pain is a common source of pediatric visits to...
When laboratory mice were modeled with colitis and treated with human umbilical cord-derived mesenchymal cells, the cells homed in on the inflamed colon and effectively ameliorated colitis, reported a study published in a recent issue of Cell Transplantation (20:9), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/. According to study corresponding author Dr. Zhong Chao Han of the Institute of Hematology, Chinese Academy of Sciences and Peking Union of Medical...
A large-scale study of medical claims data shows that introducing sophisticated biologic therapies early in the course of treatment for Crohn's disease improves response to medication and reduces the need for surgery. There is no known cure for Crohn's disease, and traditional treatment is focused on a "step-up" strategy of managing inflammatory symptoms, starting with simpler and less costly oral medications such as aminosalicylates (5-ASAs) and corticosteroids, and escalating through a...
